SAM 258.50 Boston Beer Company $SAM Hit a 52 week high of

New Post Public Reply Private Reply Replies (0) Message Board
DennyT
SAM 258.50 Boston Beer Company $SAM Hit a 52 week high of 258.94 Currently at 258.50 -0.40 -0.15% With a day low of 258.49 and a total volume of 3,978.

SAM Boston Beer Company Recent Headline News

Insider Trading Alert - CTIC, SAM And DGI Traded By Insiders
at The Street - Fri Nov 07, 10:00AM CST
Stocks with insider trader activity include CTIC, SAM and DGI
DGI: 28.56 (-0.39), SAM: 262.83 (+3.93), CTIC: 2.10 (-0.03)

2014 Cider Market Insights USA
M2 - Fri Nov 07, 5:27AM CST
Research and Markets (http://www.researchandmarkets.com/research/5zgxdx/cider_market) has announced the addition of Canadean Ltd's new report "Cider Market Insights USA" to their offering. The Cider Market Insight USA report contains detailed brand distribution and packaging data and analysis across the USA cider market for 2013. Brand and packaging volume data is available whilst value data is also available for distribution data. Text analysis reveals the drivers behind the data. Cider Market Insight reports provide detailed data and textual analysis of the beer category and the report contains four sections plus an Executive Summary a concise summary of the report including key findings and drivers. Key Findings - The cider market sees strong growth. - Further growth potential for the category remains. - Angry Orchard enjoys excellent performance. Brand - Alcoholic Strength - Cider Type - Brand - Brand Owner - Brewed In - Calorie Rating - Country of Origin - Geographic Scope - Geography - Local Operator - Local Segment - Modus Operandi - Price Segment - PL indicator - Trademark Brand Distribution - Off-premise - Off-premise sub channel - On-premise - On-premise sub channel - Price Segmentation Packaging - Pack Material - Pack Type - Pack Size Key Topics Covered: Section 1 Market Update - Channel Analysis - Cider Legislation and Taxation Tables - Cider Pricing Tables - Cider Data Tables Section 2 Brewer Profiles - Brewer Profiles - Boston Beer Co. Inc. - Vermont Hard Cider Company - Hornsby's Pub Draft Cider Ltd - Crispin Cider - Minor Cider Companies For more information visit http://www.researchandmarkets.com/research/5z...der_market Source: Canadean Ltd
SAM: 262.83 (+3.93)

Molson Coors Lags Q3 Earnings, Revenues on Low Volumes - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Thu Nov 06, 10:01AM CST
Global brewer Molson Coors Brewing Company (TAP) posted adjusted earnings of $1.46 per share in the third quarter of 2014, missing the Zacks Consensus Estimate of $1.50 per share by 2.67%.
POST: 37.46 (+0.18), MKC: 72.61 (-0.15), SAM: 262.83 (+3.93), TAP: 76.37 (-0.81)

Sirius XM, Boston Beer, and Starbucks Earnings Review
Sean O'Reilly and Nathan Hamilton, The Motley Fool - Motley Fool - Wed Nov 05, 7:00AM CST
Investors are in the midst of earnings season and dozens of top companies have released earnings. In this edition of  Where the Money Is Motley Fool Consumer Goods Analysts Nathan Hamilton and Sean O'Reilly discuss the latest results from Sirius XM...
SBUX: 77.65 (-0.14), SAM: 262.83 (+3.93), KORS: 69.69 (-0.26), SODA: 21.60 (-0.40), SIRI: 3.48 (+0.03)

Diageo Ups Tequila Presence with Don Julio, Sells Bushmills - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Tue Nov 04, 2:19PM CST
U.K.-based brewer Diageo plc (DEO) recently inked a deal with the owners of Tequila Cuervo la Rojena SA de CV to gain full control of the tequila brand Don Julio.
MNST: 106.88 (-1.51), GMCR: 154.49 (+1.59), SAM: 262.83 (+3.93), DEO: 117.79 (+1.49)

Uptrend Call Working As Boston Beer Stock Rises 11.0% (SAM)
Comtex SmarTrend(R) - Mon Nov 03, 11:17AM CST
SmarTrend identified an Uptrend for Boston Beer (NYSE:SAM) on October 16th, 2014 at $221.57. In approximately 3 weeks, Boston Beer has returned 11.05% as of today's recent price of $246.05.
SAM: 262.83 (+3.93)

Boston Beer Surges on Solid Q3 Earnings, 2014 View Intact - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Fri Oct 31, 11:40AM CDT
Shares of Boston Beer Co. Inc. (SAM) surged 9.1% during yesterday's after hours trading session following the company's announcement of strong financial results for the third quarter of 2014.
DPS: 70.08 (+0.13), MNST: 106.88 (-1.51), SAM: 262.83 (+3.93)

Boston Beer Co., Inc. Earnings: Cheers to a Great Quarter
Steve Symington, The Motley Fool - Motley Fool - Thu Oct 30, 6:22PM CDT
It's time for a toast, ladies and gentlemen, because  Boston Beer Co.   just drank Wall Street under the table, yet again. Boston Beer announced that third-quarter revenue climbed 25% year over year, to $269.7 million, driven primarily by a 23%...
SAM: 262.83 (+3.93)

Boston Beer Reports Third Quarter 2014 Results
PR Newswire - Thu Oct 30, 3:15PM CDT
The Boston Beer Company, Inc. (NYSE: SAM) reported third quarter 2014 net revenue of $269.7 million, an increase of $53.3 million or 25% over the same period last year, mainly due to core shipment growth of 23%. Net income for the third quarter was $37.9 million, or $2.79 per diluted share, an increase of $12.2 million or $0.90 per diluted share from the third quarter of 2013. This increase was primarily due to shipment increases and lower than expected operating costs per barrel during the third quarter due to lower employee benefit costs and the timing of certain advertising promotional and selling expenses.
SAM: 262.83 (+3.93)

18 Rare Beers That You Can Only Find Right Now
at The Street - Thu Oct 30, 10:23AM CDT
Wet hop beers are a rare treat that only come out in the fall. They are made by using hops right off the vine. Here are 18 you should try.
SAM: 262.83 (+3.93)

Will Boston Beer (SAM) Surprise This Earnings Season? - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Tue Oct 28, 4:40PM CDT
Boston Beer Co. Inc. (SAM), the producer and seller of alcohol beverages in the United States, is expected to report its third-quarter 2014 results on Oct 30.
LB: 76.02 (+0.41), DIS: 89.23 (-0.77), SAM: 262.83 (+3.93), DF: 16.30 (+1.88)

3 Things to Watch When Boston Beer Co., Inc. Reports Earnings
Steve Symington, The Motley Fool - Motley Fool - Tue Oct 28, 12:49PM CDT
For many, the beginning of fall is signaled by dropping temperatures, changing leaves, and pumpkin spice lattes. But I like to keep my eyes peeled for the first batch of Boston Beer 's Samuel Adams OctoberFest to hit store shelves. On Wednesday...
SAM: 262.83 (+3.93)

Constellation Brands (STZ) to Issue, Redeem Senior Notes - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Tue Oct 21, 5:00PM CDT
Constellation Brands (STZ) recently announced the pricing of Senior Notes for a public offering worth $800 million.
HAIN: 108.04 (+0.36), SAM: 262.83 (+3.93), STZ: 93.50 (-0.06)

Critical Alerts For Boston Beer, Apollo Group, Opko Health, Vale and Silver Wheaton Released By InvestorsObserver
PR Newswire - Mon Oct 20, 8:31AM CDT
InvestorsObserver issues critical PriceWatch Alerts for SAM, APOL, OPK, VALE and SLW.
OPK: 8.59 (+0.27), VALE: 9.22 (-0.21), SLW: 18.26 (-0.60), SAM: 262.83 (+3.93), APOL: 28.95 (-0.49)

Craft Beer: The 3 Biggest Threats to the Industry
Sean Williams, The Motley Fool - Motley Fool - Sat Oct 11, 12:59PM CDT
Source: Brewers Association. The old adage states that "nothing goes up forever," but the craft beer industry would prefer to have you think otherwise. Since the late 1970s, microbreweries have been popping up like weeds across the country, with...
BUD: 109.18 (+0.84), BREW: 13.67 (+0.08), SAM: 262.83 (+3.93)

Constellation Brands Q2 Earnings Up Y/Y, Misses Estimates - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Thu Oct 02, 8:58AM CDT
Constellation Brands' (STZ) adjusted earnings for the second quarter of fiscal 2015 jumped 15.6% year over year to $1.11 per share.
BUD: 109.18 (+0.84), SAM: 262.83 (+3.93), TAP: 76.37 (-0.81), STZ: 93.50 (-0.06)

4 Consumer Goods Stocks to Buy in October
Motley Fool Staff - Motley Fool - Thu Oct 02, 7:43AM CDT
When it comes to buying what you know, investors can often find many good stock choices in the consumer goods segment. We asked some of our top contributors covering consumer goods stocks to weigh in on their choice for a stock to buy in October....
NFLX: 386.90 (+2.74), AMCX: 61.34 (-0.60), SAM: 262.83 (+3.93), SIRI: 3.47 (+0.02), LULU: 43.14 (-0.62)

Craft Brew Alliance (BREW) in Focus: Stock Rises 5.5% - Tale of the Tape
Zacks Equity Research - Zacks Investment Research - Tue Sep 30, 7:44AM CDT
Craft Brew Alliance (BREW) was a big mover last session, as the company saw its shares jump over 5% on the day.
BREW: 13.67 (+0.08), SAM: 262.83 (+3.93), TAP: 76.37 (-0.81)

Can a True-Blue American Beer Survive Being Sold to Russia?
Rich Duprey, The Motley Fool - Motley Fool - Sun Sep 28, 10:00AM CDT
Call it what you want: the end of an era, a testament to our global economy, or proof that it's truly the end of days. However you view it, the iconic true-blue American brewer, Pabst Brewing, has been sold to a Russian beverage company. Oasis...
BUD: 109.18 (+0.84), TAP: 76.37 (-0.81), SAM: 262.83 (+3.93)

Starbucks' Pumpkin Spiced Latte and 10 More Ways to Get a Pumpkin Fix
at The Street - Mon Sep 22, 3:47PM CDT
Starbucks' pumpkin spice latte isn't the only way to get your pumpkin fix. Here are 10 other ways to enjoy the flavor this season.
SBUX: 77.65 (-0.14), BUD: 109.18 (+0.84), MDLZ: 37.59 (-0.17), JAH: 66.41 (+0.18), SAM: 262.83 (+3.93), TWTR: 39.96 (-0.35), KKD: 19.50 (+0.20), K: 63.86 (+0.20)
Scroll down for more posts ▼

Top 10 Most Recent News Articles

Ivonescimab Promises New Hope for Advanced BTC Patients

Updated Category News Views 190

Shifting the Paradigm in Biliary Tract Cancer Treatment Here's the scoop from the bustling world of oncology: the trial of Ivonescimab plus chemotherapy is stirring waves among experts in advanced biliary tract cancer (BTC). Contrary to the usual drowsy mornings with coffee and market pages, this data from Hong Kong wasn't about Wall Street this time. This trial might...

Continue Reading
Johnson & Johnson's JNJ-6143 Shines in Prostate Cancer Study

Updated Category News Views 230

Prostate Cancer's Persistent Challenge No one in the healthcare game needs the reminder: prostate cancer is no walk in the park, especially for those grappling with advanced stages. Now picture this—you're on your sixth treatment, and the cloud is not lifting. It's a battle that never ends, with traditional therapies sometimes barely holding the line. JNJ-6143's New...

Continue Reading
TORRAS Cases Balance Protection with Slim Design for 2026

Updated Category News Views 144

Are Slim iPhone Cases Really Protecting Your Investment? Anyone who's dropped a brand-new phone knows the pain of watching your investment smack the concrete. But hey, welcome to 2026, where Consumer365's latest rundown on iPhone protective gear turns the spotlight on TORRAS. These folks grabbed attention with their Q3 Air and Q3 Air Pro cases, crafted for iPhone 18 Pro...

Continue Reading
Spooky Dining at CARNE: A Halloween Hit in Oxnard

Updated Category News Views 242

A Festive Transformation at CARNE Rolling into Oxnard, you're met with an unconventional dining spectacle at CARNE. It's not your average restaurant fare as they've pulled out the stops with their spirited Halloween pop-up, A Nightmare at CARNE. Channeling the eerie charm of "The Nightmare Before Christmas," this temporary transformation morphs the venue into a lively,...

Continue Reading
LexisNexis Debuts AI-Guided Field Clarity at IACP 2026

Updated Category News Views 59

LexisNexis Takes a Serious Step Forward The world of law enforcement reporting just got a shake-up. LexisNexis Coplogic Solutions launched a souped-up version of its Desk Officer Reporting System (DORS) at the IACP 2026 event. They paired DORS with Field Clarity, a newfangled AI-powered assistant that aims to make police reporting slicker and more accurate. You can bet...

Continue Reading
RYBREVANT's Promising Results in HNSCC Treatment

Updated Category News Views 80

Impressive Outcomes for RYBREVANT FASPRO in Head and Neck Cancer Tucked away in the endless cycle of drug trials, a glimmer of hope shines through with new data on RYBREVANT FASPRO in treating head and neck squamous cell carcinoma (HNSCC). This science talk might not rattle the ticker tape directly on NYSE:JNJ, but it has all the makings of a game-changer in the oncology...

Continue Reading
Survivors Secure $800M Settlement with NY Archdiocese

Updated Category News Views 299

Massive Settlement: A Long-Awaited Justice Here's a different kind of news that's hitting like a thunderbolt. Over 1,300 survivors of abuse have finally struck a landmark deal with the Archdiocese of New York. Not only are the numbers staggering, but the relief for these individuals is palpable. We're talking about more than $800 million on the table here. That's some...

Continue Reading
Innovent's IBI3001 Shows Promise in Phase 1 Trials

Updated Category News Views 242

Pioneering Path with IBI3001 at ESMO 2026 Navigating through the crowded landscape of oncology trials, Innovent Biologics recently rolled out some riveting Phase 1 clinical data for their new darling, IBI3001. Top brass from Innovent took to the European Society for Medical Oncology (ESMO) Congress stage to lay bare their findings. Obviously, when you're presenting a...

Continue Reading
Monster Energy Unleashes Gaming Frenzy at Cosm L.A. Event

Updated Category News Views 96

Where Energy Drinks and Digital Reality Collide Monster Energy sure knows how to throw a party, especially when it hinges on something as electrifying as Call of Duty: Modern Warfare 4. Imagine this: Cosm Los Angeles is decked out with a massive 87-foot LED dome, and every gamer, celeb, and influencer ready to dive right in. You can't make this stuff up. They've mashed...

Continue Reading
Hims & Hers Faces FTC Heat: Investor Class Action Looms

Updated Category News Views 104

Trouble Is Brewing for Hims & Hers Investors This isn't your typical quiet stroll through the park when it comes to Hims & Hers Health, Inc. (NYSE: HIMS). We're talking about a full-blown legal showdown that's unfolding faster than you can say 'telehealth scandal.' October 25, 2026, saw the kind of announcement that makes seasoned investors' hearts skip a beat if they've...

Continue Reading

Top 5 Most Recently Viewed Articles

Michael Burry Steps Back: Scion Asset Management Shuttered

Updated Category News Views 409

Michael Burry Withdraws Scion Asset Management Registration Michael Burry, renowned for his insightful market predictions, has recently decided to de-register his hedge fund, Scion Asset Management, LLC. This decision marks a significant transition in Burry's investment journey. Understanding the De-Registration Process According to the Securities and Exchange...

Continue Reading
Delta Air Lines Takes Legal Action Against CrowdStrike Over Disruption

Updated Category News Views 540

Delta Air Lines Challenges CrowdStrike in Court Delta Air Lines (NYSE: DAL) has taken a bold step by filing a lawsuit against CrowdStrike (NASDAQ: CRWD), arising from significant operational disruptions caused by a software update. This action is taking place in a Georgia state court, specifically the Fulton County Superior Court. Mass Flight Disruptions and Their...

Continue Reading
Innovative LungFit PH Gains Approval for Use in Australia

Updated Category News Views 178

Introduction of LungFit PH in Australia Beyond Air, Inc. (NASDAQ: XAIR) has exciting news for the medical field as it recently received market authorization for its LungFit PH system from the Australian Therapeutic Goods Administration (TGA). This development positions LungFit PH as a Class IIb medical device, designed to provide a controlled application of nitric oxide...

Continue Reading
Integral Molecular Introduces Paratope-PLUS™ for Antibody Claims

Updated Category News Views 169

Integral Molecular Unveils Paratope-PLUS™ for Enhanced Antibody Patenting This innovative technology aligns with new USPTO guidelines for writing robust antibody patent claims and supports advanced antibody engineering for unique intellectual property. Integral Molecular has launched a revolutionary service named Paratope-PLUS™. This new technology aims to improve...

Continue Reading
Nauticus Robotics Growth in Q2: A Positive Outlook Ahead

Updated Category News Views 223

Nauticus Robotics Shows Strong Growth Trajectory in Q2 Nauticus Robotics, Inc. (NASDAQ: KITT), a leading innovator in subsea robotics and software, has demonstrated remarkable momentum in its financial results for the second quarter. The company continues to expand its market presence and innovate its service offerings, reflecting a strong commitment to long-term,...

Continue Reading